JPRN-UMIN000009963已完成未知
Phase II Clinical Trial of Gemcitabine and Irinotecan for Unresectable and Recurrent Pancreatic Cancer - Phase II Tial of Gem+CPT-11 for Unresectable PC
Osaka Medical Center for Cancer and CVD0 个研究点目标入组 40 人开始时间: 2013年2月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Lung fibrosis or intestinal pneumoni, and anamnesis or imaging findings. 2) Severe infection. 3) Severe complication. (heart failure, angina pectoris, arrhythmia, diabetes , intestines paralysis, ileus, myocardial infarction within 6 months after the onset.) 4) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy. 5) Watery diarrhea. 6) Jaundice. 7) Uncontrolled pleural or abdominal effusion. 8) Severe drug hypersensitivity. 9) History of other active malignancy. 10) Severe mental illness 11) Patients who are judged inappropriate for the entry into the study by the investigater.
研究者
相似试验
招募中
2 期
Phase II randomized trail of Gemcitabine and Irinotecan in Patients with Platinum Refractory and Resistant Mullerian carcinoma (tailored dose vs optimal dose chemotherapy)Patients with platinum refractory and resistant Mullerian carcinoma (ovarian cancer, fallopian tubal, primary peritoneal cancer)JPRN-UMIN000006999School of Medicine, Chiba University64
已完成
1 期
Phase I/II Trail of Gemcitabine and Irinotecan in Patients with Platinum Refractory and Resistant Ovarian cancer.Patients with platinum-refractory and &#8211resistant ovarian cancer ( including fallopian tube, primary peritoneal cancer)JPRN-UMIN000004449School of Medicine, Chiba University25
已完成
1 期
Phase I/II Study of Irinotecan and Gemcitabine in Pediatric, adolescent and Young Adult Patients with Relapsed or Refractory Solid TumorsRelapse/refractory pediatric/AYA solid tumorJPRN-UMIN000020144Group for "combination chemotherapies for refractory Adolescent and Young Adult solid tumors "10
招募中
不适用
Phase II trial of gemcitabine/cisplatin/s1 for inoperable biliary tract cancerBirialy tract cancerJPRN-UMIN000016913Jikei University school of Medicine30
已完成
2 期
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomaNL-OMON39557Academisch Medisch Centrum16